Analyst Ratings January 23, 2026

Truist Increases Intel Price Estimate to $49 Citing Optimism in 14a Foundry Development

Despite solid Q4 results and bullish foundry outlook, Intel faces supply and cost challenges affecting guidance

By Marcus Reed INTC AMD
Truist Increases Intel Price Estimate to $49 Citing Optimism in 14a Foundry Development
INTC AMD

Truist Securities has raised its price target for Intel to $49 from $39, maintaining a Hold rating amid the company's robust fourth-quarter performance and improved outlook on its 14a manufacturing process ramp. Intel's shares trade near a 52-week high, supported by strong data center and AI revenue growth, though supply constraints and cost pressures temper near-term forecasts. Analyst opinions remain mixed with other firms offering varied price targets and ratings reflecting both encouragement from recent results and caution over future guidance.

Key Points

  • Truist Securities raises Intel's price target to $49 from $39, maintaining a Hold rating amid optimistic 14a foundry prospects.
  • Intel's Q4 results surpassed expectations driven by Data Center and AI revenue growth, although first-quarter guidance fell below consensus due to supply constraints and costs.
  • Analyst opinions remain mixed, with Benchmark and Northland increasing targets and maintaining Buy ratings, while TD Cowen and Cantor Fitzgerald take more cautious stances.

Truist Securities adjusted its price objective for Intel Corporation (NASDAQ: INTC) upward to $49.00 from the prior level of $39.00, while retaining a Hold rating on the chip manufacturer’s stock. At the time of this update, Intel shares are trading at approximately $54.32, remaining just under 1% beneath its recent 52-week peak of $54.60. The stock has surged impressively by 15.67% during the past seven days. According to proprietary valuations from InvestingPro, Intel's current valuation appears elevated compared to its estimated fair value.

Intel has surpassed analyst expectations for the fourth quarter, demonstrating notable strength in Data Center and Artificial Intelligence (DCAI) segment revenues, along with improved margins and earnings per share metrics. However, despite these better-than-anticipated results, the company’s guidance for the first quarter falls significantly short of consensus projections, reflecting ongoing operational challenges stemming from supply bottlenecks and elevated cost structures.

Truist highlights that the company has adopted a more optimistic tone regarding demand dynamics and reported progress toward securing an external customer for its 14a process node manufacturing. This positive shift in the outlook for the 14a foundry ramp-up is chiefly responsible for the increased price target. Notably, Intel's Price-to-Earnings (P/E) ratio stands at a strikingly high 1200, indicating substantial investor enthusiasm despite recent profitability being modest at only $0.05 per share over the previous year.

Despite raising the price target, Truist has lowered its earnings per share forecast for calendar year 2027 to $0.87 from $1.00, attributing the decline to anticipated higher costs of goods sold and impacts from non-controlling interests which are expected to weigh on profitability.

Within Truist's broader sector analysis, investors aiming for exposure to the robustness of x86 architecture combined with growing GPU market traction are advised to consider Advanced Micro Devices (AMD), which Truist rates a Buy. Those interested in comprehensive analyses of Intel’s financial positioning, valuation benchmarks, and additional strategic insights can refer to InvestingPro’s detailed Pro Research Report covering over 1,400 US equities, including Intel.

Additional analyst commentary on Intel’s recent quarterly performance has been varied. Benchmark has raised its price target to $57 and continues to endorse a Buy rating, citing the strong Q4 revenue results surpassing estimates by $236 million to reach $13.674 billion. Similarly, Northland lifted its target to $54, acknowledging positive Non-GAAP earnings per share surprises, albeit with cautionary notes on existing capacity constraints affecting first-quarter guidance.

Conversely, TD Cowen maintains a Hold rating with a price expectation of $50, citing alignment of earnings with forecasts but expressing reservations over the lowered outlook. Cantor Fitzgerald maintains a Neutral stance with a $45 target, noting surprise at the stock's 47% year-to-date appreciation. Rosenblatt Securities increased its price target from $25 to $30 while upholding a Sell rating, attributing the share price gains largely to market anticipation of forthcoming positive news.

These divergent analyst perspectives reflect a landscape of cautious optimism surrounding Intel, balancing recent strong operational results with concerns about near-term supply chain pressures and profitability constraints.

Risks

  • Supply chain disruptions and elevated costs continue to pressure Intel's operational performance, impacting near-term earnings.
  • High valuation metrics relative to profitability could expose investors to downside risks if expectations are not met.
  • Capacity constraints in manufacturing may limit Intel’s ability to meet demand, as reflected in conservative guidance projections.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026